Chemotherapy Related Severe Cardiac Dysfunction - Case Report.

Autor: Cherata DA; Departament of Cardiology, 'Filantropia' Municipal Hospital, Craiova, Romania, PhD student., Cârstea D; Departament of Cardiology, 'Filantropia' Municipal Hospital, Craiova, Romania., Zaharie M; Departament of Cardiology, 'Filantropia' Municipal Hospital, Craiova, Romania., Bătăiosu C; Departament of Cardiology, Emergency County Hospital, Craiova, Romania., Lungulescu D; Oncolab, Oncology Medical Center.
Jazyk: angličtina
Zdroj: Current health sciences journal [Curr Health Sci J] 2015 Oct-Dec; Vol. 41 (4), pp. 395-400. Date of Electronic Publication: 2015 Dec 22.
DOI: 10.12865/CHSJ.41.04.17
Abstrakt: Cardiotoxicity is the most important side effect of cancer therapy resulting in increased patient morbidity and mortality, therefore understanding its occurrence mechanism and a correct and early diagnosis are essential for patients at risk of irreversible heart failure. We present the case of a patient who developed cancer therapeutics-related cardiac dysfunction, emphasizing the importance of regular echocardiographic evaluation for early detection of subclinical cardiac dysfunction and further cardiac monitoring. More sensitive parameters should be used to predict cardiotoxicity because the probability of cardiac function recovery diminishes in time, despite optimal heart failure treatment.
Databáze: MEDLINE